Abstract
As trans-membrane proteins located in cytoplasm and organelle membrane, potassium (K+) channels are generally divided into four super-families: voltage-gated K+ channels (Kv), Ca2+-activated K+ channels (KCa), inwardly rectifying K+ channels (Kir) and two-pore domain K+ channels (K2P). Since dysfunctions of K+ channels would induce many diseases, various studies toward their functions in physiologic and pathologic process have been extensively launched. This review focuses on the recent advances of K+ channels in tumor progression, including the brief introduction of K+ channels, the role of K+ channels in tumor cells, the possible mechanism of action at cellular level, and the possible application of K+ channel modulators in cancer chemotherapy.
Keywords: Cancer chemotherapy, Kv, KCa, Kir, K2P, K+ channel modulators, mechanisms of action
Current Topics in Medicinal Chemistry
Title: Research Toward Potassium Channels on Tumor Progression
Volume: 9 Issue: 4
Author(s): Zheng Shen, Qian Yang and Qidong You
Affiliation:
Keywords: Cancer chemotherapy, Kv, KCa, Kir, K2P, K+ channel modulators, mechanisms of action
Abstract: As trans-membrane proteins located in cytoplasm and organelle membrane, potassium (K+) channels are generally divided into four super-families: voltage-gated K+ channels (Kv), Ca2+-activated K+ channels (KCa), inwardly rectifying K+ channels (Kir) and two-pore domain K+ channels (K2P). Since dysfunctions of K+ channels would induce many diseases, various studies toward their functions in physiologic and pathologic process have been extensively launched. This review focuses on the recent advances of K+ channels in tumor progression, including the brief introduction of K+ channels, the role of K+ channels in tumor cells, the possible mechanism of action at cellular level, and the possible application of K+ channel modulators in cancer chemotherapy.
Export Options
About this article
Cite this article as:
Shen Zheng, Yang Qian and You Qidong, Research Toward Potassium Channels on Tumor Progression, Current Topics in Medicinal Chemistry 2009; 9 (4) . https://dx.doi.org/10.2174/156802609788317874
DOI https://dx.doi.org/10.2174/156802609788317874 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Extracellular Vesicles Isolated from Mesenchymal Stromal Cells Primed with Hypoxia: Novel Strategy in Regenerative Medicine
Current Stem Cell Research & Therapy Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Bioengineering RNA Silencing Across the Life Kingdoms
Recent Patents on Biotechnology Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Current Medicinal Chemistry Bioavailability Challenges Associated with Development of Anti-Cancer Phenolics
Mini-Reviews in Medicinal Chemistry The Role of Obesity in the Development of Polycystic Ovary Syndrome
Current Pharmaceutical Design New Insight into P-Glycoprotein as a Drug Target
Anti-Cancer Agents in Medicinal Chemistry Mitophagy in Carcinogenesis and Tumour Progression- A New Paradigm with Emerging Importance
Anti-Cancer Agents in Medicinal Chemistry VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Current Psychiatry Reviews Synthesis and Biological Activity of 3-N-Substituted Estrogen Derivatives as Breast Cancer Agents
Mini-Reviews in Medicinal Chemistry (Phospho)lipid-based Nanosystems for Skin Administration
Current Pharmaceutical Design Role of Phytochemicals in the Prevention of Menopausal Bone Loss: Evidence from In Vitro and In Vivo, Human Interventional and Pharmacokinetic Studies
Current Medicinal Chemistry Membrane Disrupting Lytic Peptides for Cancer Treatments
Current Pharmaceutical Design Developing Phytoestrogens for Breast Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors
Current Pharmaceutical Design Organ Preference of Cancer Metastasis and Metastasis-Related Cell Adhesion Molecules Including Carbohydrates
Cardiovascular & Hematological Disorders-Drug Targets Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Current Pharmaceutical Design Subject Index To Volume 9
Combinatorial Chemistry & High Throughput Screening